Alessandro Sette
Alessandro Sette
Unknown affiliation
Verified email at liai.org
TitleCited byYear
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
A Sette, A Vitiello, B Reherman, P Fowler, R Nayersina, WM Kast, ...
The Journal of Immunology 153 (12), 5586-5592, 1994
8791994
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
TM Allen, DH O'Connor, P Jing, JL Dzuris, BR Mothé, TU Vogel, ...
Nature 407 (6802), 386, 2000
8392000
Prominent role of secondary anchor residues in peptide binding to HLA-A2. 1 molecules
J Ruppert, J Sidney, E Celis, RT Kubo, HM Grey, A Sette
Cell 74 (5), 929-937, 1993
8211993
The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides
S Buus, A Sette, SM Colon, C Miles, HM Grey
Science 235 (4794), 1353-1358, 1987
8201987
Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad
DF Hunt, H Michel, TA Dickinson, J Shabanowitz, AL Cox, K Sakaguchi, ...
Science 256 (5065), 1817-1820, 1992
7521992
Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1* 0401 MHC class II molecule
JA Hill, S Southwood, A Sette, AM Jevnikar, DA Bell, E Cairns
The Journal of Immunology 171 (2), 538-541, 2003
7422003
Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A* 0201-binding residues.
MR Parkhurst, ML Salgaller, S Southwood, PF Robbins, A Sette, ...
The Journal of Immunology 157 (6), 2539-2548, 1996
6661996
Several common HLA-DR types share largely overlapping peptide binding repertoires
S Southwood, J Sidney, A Kondo, MF del Guercio, E Appella, S Hoffman, ...
The Journal of Immunology 160 (7), 3363-3373, 1998
6391998
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.
Y Kawakami, S Eliyahu, C Jennings, K Sakaguchi, X Kang, S Southwood, ...
The Journal of Immunology 154 (8), 3961-3968, 1995
6371995
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and-B polymorphism
A Sette, J Sidney
Immunogenetics 50 (3-4), 201-212, 1999
6231999
The immune epitope database 2.0
R Vita, L Zarebski, JA Greenbaum, H Emami, I Hoof, N Salimi, R Damle, ...
Nucleic acids research 38 (suppl_1), D854-D862, 2009
6122009
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells
A Bertoletti, A Sette, FV Chisari, A Penna, M Levrero, M De Carli, ...
Nature 369 (6479), 407, 1994
6081994
Differential effects of cytolytic T cell subsets on intracellular infection
S Stenger, RJ Mazzaccaro, K Uyemura, S Cho, PF Barnes, JP Rosat, ...
Science 276 (5319), 1684-1687, 1997
5841997
The immune epitope database (IEDB) 3.0
R Vita, JA Overton, JA Greenbaum, J Ponomarenko, JD Clark, JR Cantrell, ...
Nucleic acids research 43 (D1), D405-D412, 2014
5562014
Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome
SS Iyer, WP Pulskens, JJ Sadler, LM Butter, GJ Teske, TK Ulland, ...
Proceedings of the National Academy of Sciences 106 (48), 20388-20393, 2009
5542009
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach
P Wang, J Sidney, C Dow, B Mothe, A Sette, B Peters
PLoS computational biology 4 (4), e1000048, 2008
5522008
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor
MT De Magistris, J Alexander, M Coggeshall, A Altman, FCA Gaeta, ...
Cell 68 (4), 625-634, 1992
5521992
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.
B Rehermann, P Fowler, J Sidney, J Person, A Redeker, M Brown, ...
Journal of Experimental Medicine 181 (3), 1047-1058, 1995
5351995
Isolation and characterization of antigen-la complexes involved in T cell recognition
S Buus, A Sette, SM Colon, DM Jenis, HM Grey
Cell 47 (6), 1071-1077, 1986
5311986
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides
J Alexander, J Sidney, S Southwood, J Ruppert, C Oseroff, A Maewal, ...
Immunity 1 (9), 751-761, 1994
5021994
The system can't perform the operation now. Try again later.
Articles 1–20